Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

The Journal of Clinical Investigation (JCI)

Reversal of Viral and Epigenetic HLA Class I Repression in Merkel Cell Carcinoma (MCC)

Oncology, Medical August 22nd 2022

JCI Insight

Milademetan is a Highly Potent MDM2 Inhibitor in Merkel Cell Carcinoma (MCC)

Oncology, Medical August 22nd 2022

Endocrine-Related Cancer

miR-3156-5p is Downregulated in Serum of MEN1 Patients and Regulates Expression of MORF4L2

Endocrinology, Diabetes, Metabolism August 22nd 2022

MedPage Today

Hospital, Contractor Battle Over Anesthesiology Staff

All Specialties August 22nd 2022

ACP Hospitalist

Please, No More “Pimping” in Med Ed

All Specialties August 22nd 2022

MDLinx

Workplace Mistreatment of Physicians is on the Rise

All Specialties August 22nd 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form